Symmetrel
Developed to support motor control and indicated to alleviate symptoms of parkinsonian conditions.
Strengths: 100mg
Where to Check Availability
Medicine details
- Conditions
- Therapeutic class
Antiparkinsonian; Antiviral
- Pharmacological class
Adamantane derivative
- Known off-label uses
fatigue in multiple sclerosis
- Contraindications
history of epilepsy; gastric ulceration
- Precautions and warnings
may cause dizziness; avoid abrupt withdrawal
- Minor side effects
nausea; dizziness; insomnia
- Moderate side effects
peripheral oedema; confusional state
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Alliance Pharmaceuticals
- Onset Time
2–4 days
- Duration
long-term
- Storage instructions
Store below 25°C.
- Drug interactions
alcohol; anticholinergics
- Age restrictions
Use with caution in elderly.
- Pregnancy and breastfeeding
Pregnancy: avoid unless essential. Breastfeeding: avoid use.
Serious side effects
psychosis — requires immediate medical attention; seizures — requires immediate medical attention
Patient summary
Developed to support motor control and indicated to alleviate symptoms of parkinsonian conditions.
Mechanism of action
Amantadine enhances dopaminergic transmission and possesses nmda receptor antagonist properties, which helps regulate tremor and bradykinesia in neurodegenerative contexts.
Symmetrel
Developed to support motor control and indicated to alleviate symptoms of parkinsonian conditions.
Editorial Notes
- Active ingredient(s): Amantadine
- Listed indication(s): Parkinson’s Disease, Influenza A
Available option
- 120 tablets - 100 mg306-100-mg-1496